Scientists are gradually expanding their understanding of how cannabinoids interact with the body’s natural endocannabinoids. Endocannabinoids are very similar to the cannabinoids produced by the cannabis plant. Their unique interaction through receptors and enzymes located in the brain and body may result in a more balanced operation of the ECS. The ECS initiates and regulates processes that work to control and maintain the immune system, stress, mood, sleep, memory, the neurological system, reproductive system and more. It plays a vital role in chemical reactions that occur in the body. It helps with metabolism, including breaking down food, transformation of energy and cell construction. THC is the most abundant cannabinoid and is well known for the psychoactive effects it causes. CBD is increasingly gaining attention for widespread curative potential. It works with the endocannabinoid system or ECS a little differently than THC. It doesn’t bind to CB1 and CB2 receptors the way THC does. CBD allows the ECS access to its endocannabinoids, promoting more effective functioning. The receptors gather information and send and receive signals. CBD is non-psychoactive and available in a wide range of products, such as oils, capsules, edibles and ape cartridges. CBD stands for cannabidiol, and at this point, there is no evidence of any health-related problems resulting from recreational or medicinal use. CBD is normally well-tolerated. People are looking to CBD isolates, full-spectrum CBD and broad- spectrum CBD as a natural remedy without the adverse side-effects of synthetic pharmaceuticals. It is demonstrating effectiveness in treating seizures, nausea, chronic pain, inflammation, anxiety, depression, insomnia and more. The full potential of CBD is still being realized.